MRK Competitors & Alternatives
Compare Merck & Company Inc with similar stocks in the same industry
Drug Manufacturers - General
MRK
Main Stock$152.55
Tradestie Score
45
Market Cap
$225.13B
P/E Ratio
122.1
Revenue Growth
0.1%
Analyst Upside
-3.9%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$270.24
|
$448.07B | 31.8 | 42 | Compare |
|
ABBV
ABBVIE INC.
|
$264.96
|
$431.71B | 75.2 | 41 | Compare |
|
PG
Procter & Gamble Company
|
$144.68
|
$358.52B | 21.8 | 52 | Compare |
|
NVO
Novo-Nordisk A/S
|
$46.74
|
$262.92B | 11.4 | 49 | Compare |
|
AZN
AstraZeneca PLC
|
$165.98
|
$261.56B | 24.7 | 68 | Compare |
|
NVS
Novartis AG
|
$158.86
|
$254.99B | 23.6 | 50 | Compare |
|
VZ
Verizon Communications
|
$49.45
|
$184.80B | 12.8 | 35 | Compare |
|
AMGN
Amgen Inc
|
$439.33
|
$160.70B | 27.5 | 38 | Compare |
|
PFE
Pfizer Inc.
|
$28.07
|
$154.70B | 35.7 | 40 | Compare |
|
GILD
Gilead Sciences Inc
|
$146.12
|
$137.92B | - | 34 | Compare |
More MRK Analysis
Data updated: Aug 23, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry